# 331 Ataxia, Autism and NDT 2026

# 331 Ataxia, Autism and NDT is organized by MotivationsCEU and will be held from Oct 09 - 10, 2026 at Pediatric Therapy Associates, San Antonio, Texas, United States of America.

Description:
This 2-day intensive workshop focuses on treating the child diagnosed with ataxia, or autism spectrum disorders. This course is relevant to Physical and Occupational Therapists,  and their assistants, working with children of all ages that are diagnosed with neuromuscular movement disorders or autism spectrum disorders. Current research is finding that pediatric cerebellar dysfunction presents as complex involvement affecting sensory-motor, affective, communicative and cognitive function. Course content will cover various examples of how children with these impairments might present during familial, academic or community participation.

Treatment principles will focus on multisystem system impairments and contextual factors that affect balance, posture and mobility of children with cerebellar involvement. Video presentations will be used to identify subtle motoric qualities that are indicative of cerebellar dysfunction. It is recommended that participants have knowledge of contemporary NDT terminology and treatment principles to maximize potential benefit from this course.These CEU's can also be used toward NDTA re-certification.

Objectives:
Upon completion of this course, the participant will be able to:

1. Recognize the motoric presentation of ataxia/coordination disorder in autism and spectrum disorder diagnoses.
2. Apply information from current research in analysis of video presentation of children with ataxia and spectrum behavior.
3. Recognize and differentiate problems with multisystem impairments, specific system impairments and contextual factors observed in children with diagnoses of ataxia, and spectrum disorders.
4. Demonstrate treatment techniques practiced in labs applicable to treating patients with ataxia, and spectrum disorders.
5. Develop treatment plans consisting of short and long-term functional outcomes, impairment related treatment objectives and specific carryover strategies.